Connect with:
Monday / March 10. 2025

logo
mobile-logo
HomePosts Tagged "Financial results for Q3 FY25"
Agribusiness, Agro chems – Chemicals, Agro chems – Fertilizers, Agro chems – Pesticides, Company News, Finance, India, Seeds

Q3 FY25 gross profit stood at Rs. 89 crores, an increasing from Rs. 72 crores in Q3 FY24.

Best Agrolife Limited, India’s leading agrochemicals manufacturer, announced its unaudited financial results for the quarter and nine months ended December 31st, 2024, in the Board meeting held on 14th February, 2025.

Q3 FY25 Revenue from Operations declined by 13 per cent YoY to Rs 274 crores in Q3 FY25 compared to Rs. 315 crores in Q3 FY24. This decline was primarily due to the recent cyclonic conditions in southern India, which severely impacted the chilli crop, a key contributor to the region’s agricultural economy. Frequent rainfall during the season disrupted several crucial pest control sprays, exacerbating the situation.

Q3 FY25 gross profit stood at Rs. 89 crores, an increasing from Rs. 72 crores in Q3 FY24. The gross profit margin stood at 32 per cent with an improvement of 900 Bps as compared to last year showcasing the impact of higher braded sales contribution.

Q3 FY25 EBITDA (excluding other income) was at Rs. -6 crore compared to Rs. 19 crores in Q3 FY24. The EBITDA margin stood at -2 per cent with a decrease of 800 Bps on YoY basis, mainly due to higher fixed costs associated with investments in sales teams and a loss of Rs. 11 crores resulting from foreign currency fluctuations. Q3 FY25 Loss stood at Rs. 24 crores compared to Rs. 7 crores in Q3 FY24.

Commenting on the result and overall update on the Q3 FY25, Vimal Kumar, Managing Director, Best Agrolife Ltd. said, ″As we reflect on the current state of the agrochemical industry, this season has been challenging climatically and demand wise. Recent cyclonic conditions in southern India have affected the agricultural landscape, particularly in key states like Andhra Pradesh, Telangana, and Tamil Nadu. The disrupted weather patterns, delayed monsoons, and extended rainfall impacted the crop cycles, delaying and causing reduction in agrochemical consumption. Overall, we observed unfavourable market conditions, such as the drop in prices of key crops like chillies and tomatoes, making it difficult for farmers to invest in crop protection products. The quarter was further impacted by the strengthening of USD leading to incurring a foreign currency loss.

This combination of reduced demand and strained market sentiment created a challenging operating environment for the company. The revenue from operations stood at Rs 274 crores, a dip of -13 per cent (Q3FY24). We have experienced a weaker Q3 with PAT of -24 crores as compared to -7 crores in Q3FY24. The widening of the quarterly loss was primarily due to a weaker revenue from operations. We continue to see positivity in our strategy of shift towards a business-to-consumer (B2C) model, increasing the contribution of branded sales to 72 per cent in 9 months of FY25. The company’s branded business improved due to introduction of new products and witnessed a volume increase. Despite the volume growth, we saw a 20 per cent reduction in product prices impacting our overall revenue. Our institutional business saw a reduction by Rs72 crores in line with our movement to B2C segment, but the corresponding expected increase in the branded sales was impacted by the reduced demand and price erosion despite a healthy volume growth.

While these results are below our expectation, we view them as an opportunity to fine tune our operations for better margins by reducing costs, optimizing operations and building efficiencies. We remain focused on stabilizing our financial performance in the upcoming quarters. We intend to bring down costs as a percentage of sales and be better equipped to navigate the current and future challenges. Our focus on IP generation, technical R&D, new formulation research and development of innovative products will continue with renewed zeal. ″

Q3 FY25 gross profit stood at Rs.

Agribusiness, Agro chems – Chemicals, Agro chems – Fertilizers, Agro chems – Pesticides, Company News, Finance, India

. Company’s gross profit stood at Rs 129.2 in Q3 FY 25  crores Vs Rs 108.0 in Q3FY24 registering 20 per cent Y-o-Y growth.

Insecticides (India) Limited (IIL), one of India’s leading crop protection and nutrition company, has announced its financial results for the quarter and nine month ended December 31, 2024. 

Insecticides (India) Limited (IIL), one of India’s leading crop protection and  nutrition company, has announced its financial results for the quarter and nine month ended  December 31, 2024.  Company reported Rs 357.7 crores revenue from operations in Q3FY25 . Company’s gross profit stood at Rs 129.2 in Q3 FY 25  crores Vs Rs 108.0 in Q3FY24 registering 20 per cent Y-o-Y growth. Company posted Rs17.4 crores Profit After Tax in Q3 FY25 compared to Rs12.3 crores PAT in Q3 FY24 recording 42 per cent growth.

Q3 FY25 Vs. Q3 FY24 – Consolidated Financial Performance:

Particulars (Rs. Crs) Q3 FY25 Q3 FY24 Y-o-Y 9M FY25 9M FY24 Y-o-Y
Revenue from Operations 357.7 357.9 — 1,641.0 1,693.9 (3%)
Gross Profit 129.2 108.0 20% 509.5 414.5 23%
Gross Profit Margin (%) 36.1% 30.2% 31.0% 24.5%
EBITDA 30.9 26.0 19% 192.7 153.6 26%
EBITDA Margin (%) 8.6% 7.3% 11.7% 9.1%
Profit After Tax 17.4 12.3 42% 128.1 94.6 36%

Results Highlights:

• Consistent focus on margin improvement led by healthy product mix and better product  margins in Q3FY25 

• Robust growth in recent launches like Mission, Mission SC, Shinwa, Izuki in the first nine months.  B2B sales remain impacted with challenging macro market conditions.  

• Gross Profit Margin improved by 657 bps in 9MFY25 due to concentrated approach towards  both healthy product mix and higher margins in Premium Products 

• EBITDA improved by 268 bps in 9MFY25 with aggressive investment in marketing activities and  field promotions to support new launches and growth of Premium Products, increasing other  expenses

Operational Highlights:

• 10 new products launched in first nine months including patented latest technology  products  

• Launched Centran, a patented 9(3) insecticide with dual-action for paddy. It aims to boost  productivity and support farmers’ economic growth 

• Torry Super an innovative 9(3) herbicide for maize which is based on SPF technology,  developed by in-house R&D team 

• Tie up with BioPrime to bring Relieve, an exclusive biological product for the Indian  market, furthering efforts to provide sustainable solutions for Indian agriculture. 

• Received Patent for IZUKI, a fungicide for paddy. This has been developed in technical collaboration with Nissan Chemical Corporation Japan.

Commenting on the results and performance, Rajesh Aggarwal, MD of Insecticides (India) Ltd. said, “We are excited to share our robust performance during the current quarter with 42 per cent growth in PAT. This is in line with the strategic framework established at the start of the year focusing on profitable growth with higher share of Premium Products and improving its margins. The first nine months has been in line with expectations, driven by strong contributions from our premium product range, which now constitutes 62 per cent of B2C revenue and significant improvements in our EBITDA margins.”

In Q2 FY25, we acquired Kaeros Research Private Limited aimed at securing supply chains and reducing costs through direct imports. Kaeros holds import licenses and vendor approvals, providing valuable benefits. The acquisition was executed at fair value and is accretive to shareholder value. The Company’s fully paid-up capital is Rs. 4.78 crores, with land assets situated in Shamli, Uttar Pradesh used for field trials.

. Company's gross profit stood at

Agribusiness, Agro chems – Chemicals, Agro chems – Fertilizers, Company News, Finance, India

Company’s Crop Nutrition Business (CNB) continue to out-perform, revenue up by 55 per cent YOY, driven by good monsoon and execution of crop focus value added strategy.

Deepak Fertilisers and Petrochemicals Corporation Limited, one of India’s leading producers of industrial & mining chemicals and fertilisers (DFPCL) announced its results for the quarter ended December 31, 2024.

Key Highlights for Q3FY25:

Consolidated Revenues:  Company saw a strong 39 per cent growth, reaching Rs. 2,579 crores for the Q3 FY25. Company witnessed a remarkable 72 per cent increase in EBITDA, bringing it to Rs. 486 crores with a sustainable EBITDA margin improved from 15 per cent to 19 per cent. Company registered a phenomenal 318 per cent jump in Net profit reaching Rs. 253 crores.

Crop Nutrition Business (Fertilisers) Review

In Q3 FY25, manufactured bulk fertilizer achieved robust sales of 231 KMT, marking a 64% year-over-year increase. For the first 9 months, sales rose by 52 per cent, driven by above-normal monsoon rains in the operating region.

Company’s flagship products, Smartek and Croptek, saw exceptional sales growth, with volumes rising by 186 per cent and 56 per cent, respectively. This performance was driven by the successful execution of our Go-To-Market strategy and strong demand-generation initiatives. Both products focus on Nutrient Unlocking Technology, which helps improve yield per acre. Sale of specialty fertilizer Bensulf and water-soluble fertilizers was 19 KMT, up 8 per cent YoY.

Reflecting on the company’s performance, S.C. Mehta, Chairman and Managing Director of DFPCL, stated, “India faced a slightly slower start to the year, but with the government’s ongoing focus on investment-led growth and strong structural drivers, we remain confident about the future of the chemical and fertilizer industries. Our Q3 FY25 results reflect the strength of this confidence, highlighting the success of our strategic transition from commodity products to high-value specialty offerings, moving from customer to end consumers supported by effective backward integration and innovation.

Company’s Crop Nutrition Business (CNB) continue to

Agribusiness, Agro chems – Chemicals, Agro chems – Fertilizers, Agro chems – Pesticides, Company News, Finance, India

 Company’s PAT for Q3 was Rs. 525 Cr vs Rs. 243 Cr for the corresponding quarter of last year, registering a growth of 116 per cent.

 Coromandel International Limited India’s leading Agri solutions provider has reported the financial results for the quarter ended 31st December 2024. Company’s Total Income in Q3 FY25 was at Rs. 7,038 Cr vs Rs. 5,510 Cr for the corresponding quarter of last year, registering a growth of 28 per cent. Total Income for YTD Dec’24 was at Rs. 19,315 Cr vs Rs. 18,281 Cr for the corresponding period of last year, registering a growth of 6 per cent.

Company registered PAT of Rs 525 Crores in Q3 vs Rs. 243 Crore for the corresponding quarter of last year, registering a growth of 116 per cent. Company’s PAT for YTD Dec’24 was Rs 1,552 Cr vs Rs. 1,510 Cr for the corresponding period of last year, registering a growth of 3 per cent.

Company’s EBITDA for Q3 was Rs. 727 Cr vs. Rs. 358 Cr for the corresponding quarter of last year, registering a growth of 103 per cent. EBITDA for YTD Dec’24 was Rs. 2,218 Cr vs. Rs. 2,132 Cr for the corresponding period of last year, registering a growth of 4 per cent.

Review of Businesses:

Nutrient and Allied Business

The Revenue for the quarter ended Dec’24 was at Rs. 6,363 Cr as against Rs. 4,892 Cr for the quarter ended Dec’23. Profit before interest and tax was Rs. 635 Cr vs. Rs. 257 Cr in the corresponding period of the previous year.

The Revenue for YTD Dec’24 was at Rs. 17,307 Cr compared with Rs. 16,391 Cr for YTD Dec’23. Profit before interest and tax was Rs. 1,932 Cr vs. Rs. 1,928 Cr in the corresponding period of the previous year.

Crop Protection Business

The Revenue for the quarter ended Dec’24 was at Rs. 631 Cr as against Rs. 612 Cr for the quarter ended Dec’23. Profit before interest and tax was Rs. 91 Cr vs. Rs. 82 Cr in the corresponding period of the previous year.

The Revenue for YTD Dec’24 was at Rs. 1,937 Cr compared with Rs. 1,890 Cr for YTD Dec’23. Profit before interest and tax was Rs. 264 Cr vs. Rs. 225 Cr in the corresponding period of the previous year.

Consolidated Results

Coromandel’s Total income for the quarter ended Dec’24 was at Rs. 7,049 Cr vs. Rs. 5,523 Cr for the quarter ended Dec’23. The profit after tax was at Rs. 508 Cr as against Rs. 228 Cr in the corresponding period of the previous year.

Coromandel’s Total income for YTD Dec’24 was at Rs. 19,330 Cr vs. Rs. 18,294 Cr for YTD Dec’23. The profit after tax was at Rs. 1,476 Cr as against Rs. 1,477 Cr in the corresponding period of the previous year.

Commenting on the financial results, S. Sankarasubramanian, Managing Director & CEO, Coromandel International Limited, said, “We are pleased to report robust performance in Q3 FY25, driven by strong sales volumes in Nutrients and crop protection segments, operational excellence across businesses and continued execution of our strategic initiatives. This was further aided by strong tailwinds such as good monsoon, higher reservoir levels and increased crop sowing in our target markets. Recovery in global agrochemicals market, coupled with strong performance of innovative, in-licensing products have supported growth in Crop Protection segment.

The recent Bhumi Pooja for the new 750,000 MT per annum of NPK granulation train at Kakinada marks another significant milestone in our journey to strengthen fertiliser manufacturing capabilities. This project, alongside the ongoing Phosphoric Acid and Sulphuric Acid plants at Kakinada, is progressing well and is expected to bolster our domestic phosphatic fertiliser capacities”.

 Company’s PAT for Q3 was Rs. 525

Agribusiness, Agro chems – Chemicals, Company News, Finance, India, Inputs

Company’s revenue from operations grows 10.4 per cent Y-O-Y to Rs 445.27 Crore in Q3 FY25 and EBITDA improves 21.6 per cent Y-O-Y to Rs. 75.56 Crore.

Dhanuka Agritech Limited, one of India’s leading crop protection companies listed on BSE and NSE, has announced financial results for the third quarter of the 2024-25 fiscal year, reporting strong growth across key performance indicators, Dhanuka Agritech remains on track with its goals and initiatives.

Gurugram-headquartered firm clocked Rs. 55.04 crore profit during October-December quarter 3 of FY’25, up 21.3 per cent from the same quarter of the previous fiscal year.

Management’s Perspective on Q3FY25 Performance

Reflecting on the company’s second-quarter performance, Mahendra Kumar Dhanuka, Chairman of Dhanuka Agritech, stated, “Our Q3 performance reflects strong demand and strategic planning, supported by efficient distribution and farmer’s support. The progress we’ve made is a result of our focus on innovation, operational efficiency, and our commitment to integrity and environmental responsibility. We’ll continue pushing for even greater success in the future.”

Dhanuka added, “This season has been highly promising, with substantial acreage in key crops, as anticipated. A favorable winter season has further strengthened demand, setting a positive trajectory. Looking ahead, we are well-positioned to continue our growth and enhance our product offerings, all while delivering exceptional value to our distribution network and customers”.

Highlights:

Dhanuka Agritech has successfully concluded its INR 165 crore strategic acquisition deal for international rights to foray into global markets and distribution of its two prominent fungicides, Iprovalicarb and Triadinenol from Bayer AG.

Financial Performance Update

INR crore (Unless otherwise stated)Q3FY25Q3FY24YoY (changed %)
Revenue from Operations 445.27403.2410.4
Profit Before Tax (PBT)68.0855.8321.9
Profit After Tax (PAT) 55.0445.3721.3
EBITDA 75.5662.1621.6

Company’s revenue from operations grows 10.4 per